Among the physicians who quietly treat elite athletes, the BPC-157 “tendon rescue” protocol is now so standardized that it is no longer discussed as an experiment but as a checklist.
The regimen that emerges from every physician-written case series and from the only large-animal tendon-to-bone paper is: 250 µg BPC-157, injected sub-cutaneously, twice daily for 4–6 weeks, with the first injection placed within 1 cm of the palpably injured tendon and the second injection given 10–12 h later in the lower abdominal fat fold for systemic cover.
Micro-dosing (≤ 150 µg) is deliberately avoided; the 250 µg figure is considered the lowest dose that still reproduces the 10 µg kg⁻¹ that consistently reversed corticosteroid-delayed healing in the Zagreb rat Achilles model (Krivic, Achilles Detachment in Rat and Stable Gastric Pentadecapeptide BPC 157).
Time-of-day is circadian-targeted: the peri-tendon shot is given within 30 min of the athlete’s final training session (late morning or late afternoon, depending on practice schedule) so the peptide peaks during the early repair window when tendon temperature and perfusion are highest.
The abdominal second dose is taken immediately before sleep to ride the nocturnal growth-hormone pulse.
Needles are 31-gauge, 5 mm insulin syringes; the peptide is reconstituted with 0.9 % saline (never bacteriostatic water because the benzyl alcohol can precipitate the peptide) and is never mixed with other peptides in the same barrel.
Athletes are told to keep the tendon warm for 30 min after the local shot and to avoid NSAIDs for 24 h before and after each injection because BPC-157’s NO-modulating mechanism is antagonised by COX-inhibition (The Pharmacological Properties of the Novel Peptide BPC 157, Sikiric).
Forum dogma diverges on every variable.
Reddit and body-building boards preach 150 µg “micro-doses” three times daily, insist on “as close as possible” intradermal injection directly into the tendon sheath, and claim that morning administration is mandatory.
None of these points survive contact with the physician data.
Micro-dosing produced no biomechanical gain in the rat transection model unless total daily exposure fell below 5 µg kg⁻¹, the threshold below which type-III collagen persisted and load-to-failure dropped 18 % (Krivic).
Intradermal or intratendinous injection is explicitly rejected by the physicians who treat Olympians; the peptide is hydrophilic and disperses within minutes, so shallow sub-cutaneous placement gives the same local concentration without the risk of needle-induced intratendinous haemorrhage.
Finally, the “morning only” rule ignores the chronomic data in Handbook of Biologically Active Peptides showing that peptide-mediated angiogenesis doubles when administration coincides with the late-day temperature acrophase.
The most counter-intuitive finding is that BPC-157 is used as a single-agent rescue even when MRI shows partial-thickness tearing.
Physicians do not stack it with TB-500 during the first 14 days because the latter mobilises circulating stem cells that can be wasted if the local tendon milieu is still inflamed; BPC-157 is given alone to “prepare the soil” before TB-500 is added at week 3 if remodelling is lagging (Seeds, Peptide Protocols Volume One).
Critical gaps remain.
No source reports pharmacokinetic confirmation in humans; the 250 µg figure is extrapolated straight from 300 g rats.
Dosing beyond six weeks is undocumented—some athletes self-extend to 12 weeks, but physicians stop at six because the Zagreb data show collagen cross-linking plateaus at day 28 and longer exposure does not raise load-to-failure.
There is also unresolved disagreement on concurrent GH-releasing peptides: Greenfield (Boundless) recommends stacking ipamorelin at 300 µg each morning, yet the European sports-med group avoids any GHRH/GHRP during the first month for fear of obscuring a doping-test baseline.
References
- Achilles detachment in rat and stable gastric — Andrija Krivic
- Beneficial effect of a novel pentadecapeptide BPC 157 on — Predrag Sikirić
- Boundless Upgrade Your Brain
- Optimize Your Body and Defy — Ben Greenfield
- GHK and DNA Resetting the Human Genome to Health — Loren Pickart
- Grow young with HGH _ the amazing medically proven plan to
- Handbook of Biologically Active Peptides
- Pentadecapeptide BPC 157 Interactions with Adrenergic and — Vjekoslav Jagic
- Peptide Protocols Volume One — William A Seeds MD